Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR1 | P25024 | 20/20 | 0.82 |
| ▸ | CXCR2 | P25025 | 20/20 | 0.82 |
| ▸ | CXCR3 | P49682 | 3/20 | 0.61 |
| ▸ | CCR6 | P51684 | 3/20 | 0.61 |
| ▸ | CCR4 | P51679 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14894921 | 1.00 | CXCR1 (0.82) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| Dimethylamine SCHEMBL16165900 | 0.98 | CXCR1 (0.79) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL14905826 | 0.90 | CXCR1 (1.00) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL16165903 | 0.88 | CXCR1 (0.80) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL14894931 | 0.84 | CXCR1 (0.59) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL17004524 | 0.83 | CXCR1 (0.75) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL14905821 | 0.82 | CXCR2 (0.83) | CXCR1CXCR2CXCR3CCR6 | |
| SCHEMBL14895425 | 0.78 | CXCR1 (0.72) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL14905794 | 0.78 | CXCR1 (0.76) | CXCR1CXCR2CXCR3CCR6CCR4 | |
| SCHEMBL14895290 | 0.77 | CXCR1 (1.00) | CXCR1CXCR2CXCR3CCR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2771334-B1 | DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED PATHOLOGIES | GALDERMA RES & DEV (FR) | 2015-08-19 | — | — | EP | disclosed |
| EP-2771334-A1 | DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED PATHOLOGIES | Galderma Research & Development (FR) | 2014-09-03 | — | — | EP | disclosed |
| WO-2013061005-A1 | DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED PATHOLOGIES | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2013-05-02 | — | — | WO | disclosed |